RankAlpha logo
Back to Rankings

JNJ

Johnson JohnsonC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
JNJ vs peer average
44/100
JNJ vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 3 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ABBV is the first available peer comparator.

Direct immunology and oncology operating comparator; useful for judging whether JNJ can replace STELARA pressure with newer immunology and hematology/oncology growth as effectively as another major U.S. branded-drug franchise.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerABBVAbbVie
JNJ
Johnson Johnson
ABBV
AbbVie
Grade
C
B
Momentum
41
51
Value
62
62
Sentiment
57
54
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ABBV

JNJ / ABBV
Grade Position
Below peers
JNJ vs. peer average (C vs. C)
44/100
Momentum
41
ABBV
Value
62
ABBV
Sentiment
57
JNJ

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs JNJ
1
ABBV
ABBV
B
80/100
-1
2
MRK
MRK
B
80/100
-1
3
AZN
AZN
F
20/100
+2
4
NVS
Novartis AG ADR
C
60/100
Even
5
NVO
Novo Nordisk A/S Class B ADR
A
100/100
-2
ABBV is the first peer returned for this comparison set.